<code id='D30040C353'></code><style id='D30040C353'></style>
    • <acronym id='D30040C353'></acronym>
      <center id='D30040C353'><center id='D30040C353'><tfoot id='D30040C353'></tfoot></center><abbr id='D30040C353'><dir id='D30040C353'><tfoot id='D30040C353'></tfoot><noframes id='D30040C353'>

    • <optgroup id='D30040C353'><strike id='D30040C353'><sup id='D30040C353'></sup></strike><code id='D30040C353'></code></optgroup>
        1. <b id='D30040C353'><label id='D30040C353'><select id='D30040C353'><dt id='D30040C353'><span id='D30040C353'></span></dt></select></label></b><u id='D30040C353'></u>
          <i id='D30040C353'><strike id='D30040C353'><tt id='D30040C353'><pre id='D30040C353'></pre></tt></strike></i>

          
          WSS
          Illustration of a hospital with stacks of dollar bills on top – private equity coverage from STAT
          Adobe

          Nonprofit hospitals often get overshadowed at the J.P. Morgan Healthcare Conference, the health care industry’s swankiest investor meeting whose agenda is dominated by drugmakers and biotech companies.

          But hospitals are still the largest part of America’s health care economy, commanding nearly a third of the country’s $4.7 billion health care tab. And similar to last year, when hospitals touted their plans for expansion and hiking prices, they will have a rosy picture to sell to financiers as patients flock to their facilities.

          advertisement

          STAT spoke with attorneys, analysts, and health care executives who are attending JPM’s event or are watching from afar. Even though some of the health systems presenting at the conference just lost hundreds of millions in 2023, expect a theme of cautious optimism for the coming year from hospitals, medical groups, health insurers, and the vendors who serve them. Each of these sectors is dealing with its own challenges — namely, high labor costs and a tighter regulatory environment — but that’s not likely to be emphasized in their presentations to investors. Instead, they’ll outline their plans for emerging stronger.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Leave your comment

          Please enter your name
          Please enter your comment

          hotspot